The effects of reproductive factors on breast cancer risk appear to differ by estrogen receptor (ER) status. Menarche and first live birth (FLB) tend to occur at younger ages in AfricanAmericans (AAs) than European-Americans (EAs), and could play a role in breast cancer disparities. In the Women's Circle of Health Study (WCHS), a case-control study of breast cancer in EA and AA women, in-person interviews were conducted to collect epidemiological data, including reproductive histories. Data on ER status, abstracted from pathology reports, were available for 814 AA and 538 EA breast cancer cases, and were analyzed with 1015 AA and 715 EA controls, to evaluate associations between subgroups and age at menarche, age at FLB and the interval between those ages. Among AA women, later age at menarche (≥14 yrs) was associated with reduced risk of both ER+ and ER-breast cancer, with odds ratios (ORs) strongest for ER-disease (OR =0.57; 95% CI, 0.37-0.88); associations were weaker and non-significant for EA women. There were no significant associations with age at FLB, but AA women with a FLB within 15 years of menarche had increased risk of 95% CI, with no significant associations among EAs. In our data, earlier age at menarche and shorter intervals until FLB are associated with ER-breast cancer in AA women; differential distributions by race of these and other reproductive risk factors could contribute to the higher prevalence of ER -breast cancer in AA women.
Introduction.
Although white women of European ancestry (EA) have the highest incidence of breast cancer of all racial groups in the US, American women of African ancestry (AA) are more likely to be diagnosed at an earlier age and with more aggressive tumors (1) . Tumors that are negative for the estrogen receptor (ER), most prevalent in AA women, lack therapeutic targets and are associated with poorer survival. Until recently, there have been few explanations for these differences in tumor biology between EA and AA women, but there is accumulating evidence suggesting that differences in parity and in breastfeeding could contribute to these disparities (2) (3) (4) , with parity associated with reduced risk of ER+ breast cancer, but increased risk of ERtumors (reviewed in (3) . In several studies, younger age at first live birth (FLB) has also been associated with reduced risk of ER+, but increased risk of ER-breast cancer (5, 6) , although there are conflicting data, as recently reviewed by Martinez and colleagues (7) .
Early age at menarche is an established risk factor for breast cancer and appears to be associated with larger, more advanced tumors (8, 9) . AAs have younger age at menarche than EAs (10, 11) , hypothesized to be a contributing factor to their higher risk of early onset breast cancer (12) . Age at menarche has declined in the last two centuries, and has been consistently younger (by approximately 0.5 years) for AAs than for EAs (13) , with the decline between 1973 and 1994 greater for AAs (0.8 years) than for EAs (0.2 years) (14) .
There have been limited studies investigating potential associations between breast cancer subtypes and reproductive risk factors that may vary between AA and EA women, with mixed results (reviewed by Li (5)); few have included substantial numbers of both AA and EA women. Here we report on associations between breast cancer risk and reproductive factors according to ER status in a large study of breast cancer in AA and EA women.
Materials and Methods
Study population. The Women's Circle of Health Study (WCHS) was a case-control study designed to examine risk factors for ER-, early onset breast cancer among AA and EA women in metropolitan New York City (NYC) and in several counties in New Jersey (NJ). As previously described (15) (16) (17) , eligible cases were English-speaking women diagnosed with incident invasive or in situ breast cancer, aged 20 to 75, who self-identified as AA or EA and had no previous history of cancer other than non-melanoma skin cancer. Cases were identified in NYC hospitals with large referral patterns for AAs, and through population-based rapid case ascertainment in seven counties in NJ through the NJ State Cancer Registry. Controls were identified using random digit dialing in both NYC and NJ, and were frequency matched to cases by self-reported race and 5-year age categories. Participation rates for cases were 82.4% for AAs and 79.1% for EAs, and for controls, 52.5% (AAs) and 49.0% (EAs). With the assistance of community partners and advocates, we also recruited AA controls in NJ through churches and health fair events in the same counties in which cases were identified, to better represent the AA population at large than RDD alone (18) . In-home interviews were conducted and data collected on a number Data collection and statistical analyses. In the interview, risk factor data were collected, including age at first menstrual period (age at menarche), how many pregnancies they had had, and what the outcome of each pregnancy was. For live births, participants were asked in what month and year the pregnancy ended. History of benign breast disease (BBD) was coded as positive if the diagnosis was confirmed by a physician. Women were defined as postmenopausal if they reported that they had ceased menstruation naturally at least one year prior to reference date, or if they had both ovaries removed. Family history of breast cancer was reported breast cancer in a first degree relative.
Distributions of age at FLB and the interval between menarche and FLB differed markedly by race, with 20% of AA women having FLB before age 18, but only 2% of EAs. Similarly, the interval between menarche and FLB was < 5 years for 15% to 20% of AA women, but only for 2% of EA women. Thus, we categorized FLB and the interval between menarche and FLB according to distributions among controls specific to each of those populations. For analysis, we compared categories across controls and cases according to ER status, using chi-square tests for categorical data, and also determined p values for case-case differences between women with ER+ and ER-tumors. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using unconditional logistic regression to examine associations between age at menarche, age at FLB and the interval between those ages, and odds of ER+ and ER-breast tumors. Full models were adjusted for factors associated with the exposure or with risk of breast cancer in our data, and included age, study site, education, history of BBD, family history of breast cancer, menopausal status, body mass index (BMI) at age 20 (17) , country of origin, and reference year. Associations were evaluated among all cases and also excluding women with DCIS from the analysis. All analyses were conducted using SAS 9.3. Table 1 shows characteristics of the study participants, separately for AAs and EAs. There were no significant case-control differences in the reproductive characteristics of interest in either AAs or EAs. However, as noted above, AA women were more likely to have an early age at menarche (< 11 years of age) than EAs, younger age at FLB (< 18 years), and shorter intervals between menarche and FLB. As expected, the majority of breast cancers were invasive, rather than in situ, with a greater proportion of ER-tumors among AA women (28.6%) than among EAs (17.1%). Among EA women (Table 3) , there were no differences by ER status for age at menarche, with a suggestion of decreased risk of both ER+ and ER-breast cancer with menarche ≥ 14 years. FLB after age 25 was associated with increased risk of ER+ breast cancer (OR=1.58 ; 95% CI, 0.77-3.21), with no associations for ER-disease. Although none of the associations were significant for interval between menarche and age at FLB, there appeared to be increased risk for both ER+ and ER-breast cancer with more years (≥15) between menarche and first pregnancy. There were no differences in results when DCIS cases were excluded (data not shown).
Results
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Discussion
In this analysis of data from 814 AA and 538 EA women with breast cancer and 1723 controls, 
It is unclear why associations with hormonal and reproductive factors appear to play a more prominent role in ER -breast cancer in AAs than in EAs, including parity and breastfeeding as we have recently shown (2). AAs experience menarche at an earlier age than EAs, have more children at younger ages, and tend not to breastfeed, all factors associated with differential risk by ER status.
Thus, it is possible that these menstrual and reproductive patterns could be related to the higher prevalence of earlier onset, ER-breast cancer among AAs. Early menarche, early FLB, and short intervals between menarche and pregnancies could essentially down-shift a high hormonal milieu to younger ages, leading to more rapid development of aggressive tumors.
This area of research clearly merits further attention, and warrants not only consortia with large numbers of AA women to clarify and refine associations, but also studies to understand the biologic mechanisms underlying these associations between hormonally-related risk factors and development of ER -tumors. Ideal prospective studies would include comprehensive data on circulating hormonal levels, bone mass and breast growth during puberty and information on subsequent childbearing patterns in a multi-racial/multi-ethnic population, to better understand the mechanisms for and the basis of disparities in the development of aggressive breast cancer. 
